NeuroTrainer for ADHD

Recruiting at 2 trial locations

Overseen By Julie Schweitzer, Ph.D.

Age: < 18

Sex: Any

Trial Phase: Academic

Sponsor: NeuroTrainer

Disqualifiers: Suicidality, Psychotic disorders, Severe depression, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 37

Duration: 12 weeks

155 Participants Needed

What You Need to Know Before You Apply

What is the purpose of this trial?

This clinical trial aims to evaluate the feasibility and efficacy of NeuroTrainer cognitive training in improving attentional and executive control functions in students with and without attention-related difficulties.

Who Is on the Research Team?

Jeff Nyquist, Ph.D.

Principal Investigator

NeuroTrainer

Are You a Good Fit for This Trial?

This trial is for students aged 11-17 who meet the diagnostic criteria for ADHD, regardless of severity. Participants should have an estimated IQ of 80 or higher and struggle with attention-related difficulties.

Inclusion Criteria

I have been diagnosed with ADHD, regardless of its severity.

My IQ is estimated to be 80 or above.

I am between 11 and 17 years old.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants engage in NeuroTrainer VR-based cognitive training sessions, approximately three times a week for 12 weeks

12 weeks

36 sessions (virtual)

Follow-up

Participants are monitored for changes in ADHD symptoms and academic performance

6 months

Assessments at Week 1, Month 2, Month 3, Month 9

What Are the Treatments Tested in This Trial?

Interventions

• NeuroTrainer

Trial Overview The NeuroTrainer cognitive training program is being tested to see if it can help improve focus and executive control in young people with ADHD or hyperactivity disorders.

How Is the Trial Designed?

Group I: NeuroTrainer Intervention Experimental Treatment 1 Intervention

The NeuroTrainer intervention involves using a VR-based cognitive training program designed to improve attention and executive function in students with ADHD. Participants will engage in 30-minute sessions, approximately three times a week for 12 weeks, performing game-like tasks that integrate physical activity and adapt to their performance level.

Group II: Control Condition Active Control 1 Intervention

The control condition involves students receiving standard educational interventions without the use of NeuroTrainer. These activities include regular classroom instruction and typical academic tasks designed to support learning, without the additional cognitive training provided by the VR program.

Who Is Running the Clinical Trial?

NeuroTrainer

Lead Sponsor

Trials

2

Recruited

240+

National Institute of Mental Health (NIMH)

Collaborator

Trials

3,007

Recruited

2,852,000+

University of California, Davis

Collaborator

Trials

958

Recruited

4,816,000+